Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis

Condition:   Atopic Dermatitis Eczema
Interventions:   Drug: Administration of Placebo;   Drug: Administration of PUR0110 (Thykamine) 0.05%;   Drug: Administration of PUR0110 (Thykamine) 0.1%;   Drug: Administration of PUR0110 (Thykamine) 0.25%
Sponsor:   PurGenesis Technologies Inc.
Recruiting

https://ift.tt/2skyVNb